Samcyprone A treatment for Melanoma $RXII $XHS

RXi Pharmaceuticals Corporation, a biotechnology company, has been approved by FDA .USA, for the Orphan Drug Designation of Samcyprone.

The drug have been used for the treatment of Malignant Melanoma Stage IIb to IV.

View the full release here.